New Analysis Shows Fluvoxamine Has The Potential To Reduce Covid-19 Hospitalizations By More Than 90% - Forbes

There is an ever-expanding need for SARS-CoV-2 antivirals. A recent analysis suggests fluvoxamine may greatly reduce the risk of hospitalization in Covid patients.

In-pharmacy minute clinic with CVS Pharmacy CVS Health The United States has launched a new and innovative program called Test And Treat. This program intends to solve one of the most immediate pro… [+3852 chars]

full article...